GlassScriptPhysician profile
Ghazanfar Khadim
NPI 1427126820
$15,236.11
in general payments reported to CMS, 2019-2025
38 companies · $3,782 in 2025
The $3,782 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,540 · 2020: $1,233 · 2021: $1,354 · 2022: $1,482 · 2023: $4,210 · 2024: $1,637 · 2025: $3,782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,751 · Travel and Lodging: $3,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,751.00 |
| Travel and Lodging | $3,876.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,405.06 | 2019-2025 | Ekosonic, Watchman Access System, Eluvia |
| Medtronic, INC. | $2,067.11 | 2021-2025 | Ellipsys Vascular Access System, Onyx Frontier, Micra |
| Penumbra, INC. | $1,626.98 | 2019-2023 | Ruby Coil |
| Inari Medical, INC. | $846.83 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $648.37 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $544.77 | 2019-2025 | Jardiance |
| Philips North America LLC | $481.09 | 2019-2024 | (Ck4) Mcot |
| Bard Peripheral Vascular, INC. | $353.35 | 2024 | Crosser Iq |
| Medtronic Vascular, INC. | $349.00 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $330.65 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $325.80 | 2019-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $213.24 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $206.61 | 2022-2024 | Verquvo |
| Kestra Medical Technology Services, INC. | $194.52 | 2023-2024 | Assure Wcd |
| Cvrx, INC. | $172.77 | 2022-2024 | Barostim Neo System |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $131.43 | 2023-2025 | Onpattro |
| Siemens Medical Solutions USA, INC. | $121.93 | 2020 | |
| Cardiovascular Systems INC. | $111.56 | 2019-2021 | |
| Chiesi USA, INC. | $108.53 | 2019 | |
| Pfizer INC. | $101.18 | 2019-2022 | |
| Biotronik INC. | $99.23 | 2023-2024 | Oscar, Amvia Edge |
| Stryker Corporation | $96.29 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $91.20 | 2025 | |
| Canon Medical Systems USA, INC. | $88.34 | 2020 | |
| Abbott Laboratories | $65.17 | 2020-2023 | Confirm Rx |
| Amarin Pharma, INC. | $65.00 | 2020-2022 | |
| Abiomed | $62.03 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.83 | 2019-2023 | Camzyos |
| Thrombolex, INC. | $42.52 | 2025 | Bashir Endovascular Catheter |
| Amgen INC. | $33.81 | 2019-2024 | Repatha |
| Lundbeck LLC | $32.20 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $32.16 | 2019 | |
| Cardiva Medical, INC. | $29.85 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Jubilant Draximage, INC. | $27.68 | 2025 | Technetium Tc 99m Sestamibi |
| Cardinal Health 200 LLC | $24.22 | 2020 | |
| Angiodynamics, INC. | $19.47 | 2024 | Venacure 1470 Pro |
| Glaxosmithkline, LLC. | $17.86 | 2025 | Shingrix, Arexvy |
| Edwards Lifesciences Corporation | $15.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghazanfar Khadim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.